Blepharitis Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Key Companies - Premark Pharma (PMP2207), Tarsus Pharmaceuticals (TP-03)

As per DelveInsight, the Blepharitis Market is anticipated to evolve immensely in the coming years owing to the increasing prevalent population of Blepharitis patients in the 7MM, along with the expected entry of new therapies into the market.

DelveInsight's "Blepharitis Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Blepharitis Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Blepharitis therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Blepharitis treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Blepharitis: An Overview
According to the American Optometric Association, blepharitis is an inflammation of the eyelids in which they become red, irritated, itchy, and dandruff-like scales form on the eyelashes. It is a chronic external eye disorder resulting in red, burning, and irritated eyes which does not cause serious damage to the eyes, but it can be very uncomfortable. It can be caused by either bacteria or a skin condition, such as dandruff of the scalp or rosacea.

Blepharitis on the basis of anatomic location is of three types: Anterior Blepharitis, Posterior Bepharitis, and Mixed Anterior and Posterior Blepharitis. Anterior Blepharitis affects the front of the eyelids around the eyelashes and may be due to seborrhoeic dermatitis, may also involve the scalp, face and ears, or be due to bacterial (staphylococcal) infection. Posterior Blepharitis mainly affects the back of the eyelids, around the Meibomian glands, often associated with rosacea. Mixed anterior and posterior blepharitis is a combination of both anterior and posterior blepharitis.

The current standard of care for Blepharitis involves topical and systemic antibiotics and topical anti-inflammatories like corticosteroids and cyclosporine. The major key players include Tarsus Pharmaceuticals (TP-03) and Premark Pharma (PMP2207), and others which are in different phases of clinical development.

Blepharitis Market Key Facts
• According to the American Academy of Ophthalmology (2023), in the United States, 37% to 47% of patients seen by respondents were diagnosed with blepharitis.
• In a study by John Meyer (2022), demodex blepharitis can affect individuals of all ages, its prevalence increases with age, with more than 80% of people who are 60 and 100% of those aged over 70 years.
• According to the Atlas study (2022), over half of the patients (51%) have experienced signs and symptoms of demodex blepharitis for more than 4 years, and 58% of patients were never diagnosed with blepharitis.
• Research by Pulgarin et al. (2021), blepharitis can be present in 27.5-68.3 % of dry eye disease cases. Demodex infestation was observed in 41.6-81.25 % of the Blepharitis patients.
• In a study by Lemp et al. (2009), ophthalmologists and optometrists observe blepharitis in 37-47% of their patients.

Discover How Blepharitis Market Will Grow by 2032:
https://www.delveinsight.com/report-store/blepharitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Blepharitis Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Blepharitis therapies in the market. It also provides a detailed assessment of the Blepharitis market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Blepharitis drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Blepharitis Epidemiology
The epidemiology section covers detailed insights into the historical, and current Blepharitis patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Blepharitis Epidemiology Segmented as -
• Prevalent cases of Blepharitis in the 7 MM [2019-2032]
• Age-Specific Cases of Blepharitis in the 7 MM [2019-2032]
• Type-Specific Cases of Blepharitis in the 7 MM [2019-2032]
• Diagnosed and Treatable Cases of Blepharitis in the 7 MM [2019-2032]

Get Key Insights Into the Evolving Blepharitis Epidemiology Trends @
https://www.delveinsight.com/report-store/blepharitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Blepharitis Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Blepharitis market or expected to be launched during the study period. The analysis covers the market share by Blepharitis drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Blepharitis Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities @
https://www.delveinsight.com/sample-request/blepharitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Leading Companies in the Blepharitis Therapeutics Market Include
• Tarsus Pharmaceuticals
• Premark Pharma
And Many Others

Emerging and Marketed Blepharitis Therapies Covered in the Report Include
• TP-03: Tarsus Pharmaceuticals
TP-03 [Tarsus Pharmaceuticals] is a novel, investigational therapeutic designed to resolve the signs of Demodex blepharitis by targeting and eradicating the root cause of the disease. Lotilaner is a well-characterized anti-parasitic agent that paralyzes and eradicates Demodex mites by selectively inhibiting the GABA-Cl channels.

• PMP2207: Premark Pharma
PMP2207 [Premark Pharma] is a selective inhibitor of pro-inflammatory mediators which is an ophthalmic ointment applied to the eyelid and eyelid margin twice daily. The active agent has a well-characterized safety profile and is free from corticosteroid side effects.

Learn More About the Emerging Therapies & Key Companies in the Blepharitis Therapeutics Market:
https://www.delveinsight.com/sample-request/blepharitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Blepharitis Competitive Intelligence Analysis
4. Blepharitis Market Overview at a Glance
5. Blepharitis Background and Overview
6. Blepharitis Patient Journey
7. Blepharitis Epidemiology and Patient Population
8. Blepharitis Treatment Algorithm, Current Treatment, and Medical Practices
9. Blepharitis Unmet Needs
10. Key Endpoints of Blepharitis Treatment
11. Blepharitis Marketed Products
12. Blepharitis Emerging Therapies
13. Blepharitis Seven Major Market Analysis
14. Attribute Analysis
15. Blepharitis Market Outlook (7 major markets)
16. Blepharitis Access and Reimbursement Overview
17. KOL Views on the Blepharitis Market.
18. Blepharitis Market Drivers
19. Blepharitis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/blepharitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Mucinous Cystic Neoplasms (MCNs) Market
https://www.delveinsight.com/report-store/mucinous-cystic-neoplasms-mcns-market

Overt Hepatic Encephalopathy Market
https://www.delveinsight.com/report-store/overt-hepatic-encephalopathy-market

Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/familial-hypercholesterolemia-market-report

Lateral Epicondylitis (Tennis Elbow) Disease Market
https://www.delveinsight.com/report-store/lateral-epicondylitis-tennis-elbow-disease-market

Diverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market

Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market

Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market

Charcot-Marie-Tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market

Neurovascular Thrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Neurothrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market

Venous Leg Ulcer Market
https://www.delveinsight.com/report-store/venous-leg-ulcer-market

Genital Herpes Market
https://www.delveinsight.com/report-store/genital-herpes-market-forecast

Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market

Morquio Syndrome Market
https://www.delveinsight.com/report-store/morquio-syndrome-market

Lymphoedema Market
https://www.delveinsight.com/report-store/lymphoedema-market

Neurotrophic Keratopathy Market
https://www.delveinsight.com/report-store/neurotrophic-keratopathy-market

Oncolytic Virus Cancer Therapy Market
https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market

Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market

Advanced Wound Care (AWC) Market
https://www.delveinsight.com/report-store/advanced-wound-care-market

Opioid-related Disorders Market
https://www.delveinsight.com/report-store/opioid-related-disorders-market

Ankylosing Spondylitis (AS) Market
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market

Chronic Insomnia Market
https://www.delveinsight.com/report-store/chronic-insomnia-market

Microscopic Polyangiitis (MPA) Market
https://www.delveinsight.com/report-store/microscopic-polyangiitis-mpa-market

Esophageal Squamous Carcinoma Market
https://www.delveinsight.com/report-store/esophageal-squamous-carcinoma-market

Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market

Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market

Idiopathic Interstitial Pneumonia Market
https://www.delveinsight.com/report-store/idiopathic-interstitial-pneumonia-market

Diphtheria Market
https://www.delveinsight.com/report-store/diphtheria-market

Dyslipidemia Market
https://www.delveinsight.com/report-store/dyslipidemia-market

Thymus Cancer Market
https://www.delveinsight.com/report-store/thymus-cancer-market

Tendonitis Market
https://www.delveinsight.com/report-store/tendonitis-market

Alpha-Antitrypsin Deficiency Market
https://www.delveinsight.com/report-store/alpha-antitrypsin-deficiency-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.